Your browser doesn't support javascript.
loading
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis.
Godolphin, Peter J; Fisher, David J; Berry, Lindsay R; Derde, Lennie P G; Diaz, Janet V; Gordon, Anthony C; Lorenzi, Elizabeth; Marshall, John C; Murthy, Srinivas; Shankar-Hari, Manu; Sterne, Jonathan A C; Tierney, Jayne F; Vale, Claire L.
Afiliação
  • Godolphin PJ; MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, United Kingdom.
  • Fisher DJ; MRC Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, United Kingdom.
  • Berry LR; Berry Consultants, Austin, Texas, United States of America.
  • Derde LPG; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Diaz JV; University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
  • Gordon AC; Clinical Unit, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
  • Lorenzi E; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, United Kingdom.
  • Marshall JC; Berry Consultants, Austin, Texas, United States of America.
  • Murthy S; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Shankar-Hari M; Department of Pediatrics, University of British Columbia, Vancouver, Canada.
  • Sterne JAC; Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom.
  • Tierney JF; Department of Critical Care Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom.
  • Vale CL; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
PLoS One ; 17(7): e0270668, 2022.
Article em En | MEDLINE | ID: mdl-35802687
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article